scholarly journals Factors affecting compliance for iron chelating agents in thalassemic patients in Basrah province, Iraq

2021 ◽  
Vol 5 (4) ◽  
Keyword(s):  
Chelating Agents ◽  
Factors Affecting ◽  
Iron Chelating Agents

scholarly journals Olfactory Dysfunction in β Thalassemia Major Patients Treated With Iron-Chelating Agents

2019 ◽  
Vol 98 (8) ◽  
pp. NP125-NP130
Author(s):  
Serhan Derin ◽  
Selvet Erdogan ◽  
Murat Sahan ◽  
Mehmet Fatih Azik ◽  
Hatice Derin ◽  
...  
Keyword(s):  
Chelating Agents ◽  
Thalassemia Major ◽  
Olfactory Dysfunction ◽  
Facial Trauma ◽  
Control Group ◽  
Control Groups ◽  
History Of ◽  
And Control ◽  
Iron Chelating Agents

Ocular and ophthalmological adverse effects may be seen in β-thalassemia major (BTM) patients treated with regular blood transfusions and iron-chelating agents. We hypothesized that olfactory dysfunction may be present in this population. In this study, we aimed to investigate olfactory dysfunction in patients with BTM and determine the etiological factors. A total of 43 patients with BTM were included in the study. Forty-three patients without any nasal complaints, history of facial trauma, or nasal surgery were included as the controls. All participants had nasal endoscopy. The iron-chelating agents used, their duration of use, as well as hemoglobin and ferritin levels of the BTM patients were recorded. Sniffin’ Sticks test (SST) was used to assess olfactory functions, and BTM and control groups were compared for the results. The correlations of SST scores with the other study parameters were analyzed. Eight (18.6%) of 43 patients in the BTM group had hyposmia while none of the patients in the control group had hyposmia ( P < .001). Older age, low-hemoglobin level, and longer use of deferoxamine were found to be correlated with olfactory dysfunction. Olfactory dysfunction may be seen in BTM patients treated with iron-chelating agents. The results of this study suggest that screening for olfactory function may be needed in routine follow-up of BTM patients.

Curcuminoids as potential new iron-chelating agents: spectroscopic, polarographic and potentiometric study on their Fe(III) complexing ability

2002 ◽  
Vol 328 (1) ◽  
pp. 61-68 ◽  
Author(s):  
Marco Borsari ◽  
Erika Ferrari ◽  
Romano Grandi ◽  
Monica Saladini
Keyword(s):  
Chelating Agents ◽  
Potentiometric Study ◽  
Complexing Ability ◽  
Iron Chelating Agents

scholarly journals Protection against hepatic ischemia-reperfusion injury using iron-chelating agents with different lipophilicity. Experimental research

HPB ◽  
2020 ◽  
Vol 22 ◽  
pp. S405-S406
Author(s):  
A. Mantelou ◽  
A. Papalois ◽  
A. Papoudou-Bai ◽  
P. Gerogianni ◽  
D. Galaris ◽  
...  
Keyword(s):  
Reperfusion Injury ◽  
Experimental Research ◽  
Chelating Agents ◽  
Ischemia Reperfusion Injury ◽  
Ischemia Reperfusion ◽  
Hepatic Ischemia ◽  
Hepatic Ischemia Reperfusion ◽  
Iron Chelating Agents

Iron-Chelating Agents in Non-Iron Overload Conditions

1994 ◽  
Vol 120 (6) ◽  
pp. 490 ◽  
Author(s):  
E. E. Voest
Keyword(s):  
Iron Overload ◽  
Chelating Agents ◽  
Iron Chelating Agents

Meta-analysis of the safety of iron chelating agents

2014 ◽  
Author(s):  
Niya Li
Keyword(s):  
Chelating Agents ◽  
Meta Analysis ◽  
Iron Chelating Agents

ChemInform Abstract: 5-Hydroxypyran-4-one Derivatives as Potential Therapeutic Iron-Chelating Agents.

ChemInform ◽  
2016 ◽  
Vol 47 (26) ◽  
Author(s):  
Junpei Li ◽  
Vincenzo Abbate ◽  
Jagoda Jurach ◽  
Guoqing Zhang ◽  
Xiaole Kong ◽  
...  
Keyword(s):  
Chelating Agents ◽  
Iron Chelating Agents
Sign in / Sign up

Export Citation Format

Share Document